JWBC
TBIO

John W. Brooker & Co’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

John W. Brooker & Co’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-900
Closed -$15K – 207
2021
Q1 		$15K Buy
+900
New +$20.5K 0.01% 113

Other funds holding TBIO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

John W. Brooker & Co's TBIO Position: Q2 2021 in Review

John W. Brooker & Co sold out of Translate Bio, Inc. Common Stock (TBIO) in Q2 2021, closing a stake of 900 shares — an estimated $15K sold.

John W. Brooker & Co first reported a position in TBIO in Q1 2021 and held it in 1 quarter. The position peaked at $15K in Q1 2021. 145 funds tracked by Wall St. Rank hold TBIO as of Q2 2021.

  • John W. Brooker & Co reported no remaining Translate Bio, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • John W. Brooker & Co sold 900 Translate Bio, Inc. Common Stock shares in Q2 2021, an estimated $15K.
  • John W. Brooker & Co first reported a position in Translate Bio, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • John W. Brooker & Co's Translate Bio, Inc. Common Stock position peaked at $15K in Q1 2021.
  • 145 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q2 2021.

Based on John W. Brooker & Co's 13F filing for Q2 2021, filed 9 Jul 2021.